Physician profile
David Dang Tran
NPI 1023300266
$96,074.55
in general payments reported to CMS, 2019-2025
22 companies · $40K in 2025
The $40K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $1,456 · 2021: $271 · 2022: $747 · 2023: $9,828 · 2024: $43K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $70K · Travel and Lodging: $12K · Consulting Fee: $7,200 · Food and Beverage: $3,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $69,513.13 |
| Travel and Lodging | $12,333.00 |
| Consulting Fee | $7,200.00 |
| Food and Beverage | $3,855.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $82,894.91 | 2020-2025 | Intracept, General - Therapies, General - Pain Management |
| Relievant Medsystems, INC. | $11,172.67 | 2019-2023 | Intracept |
| Nevro Corp. | $679.14 | 2019-2023 | Senza |
| Electronic Waveform Lab, INC. | $476.95 | 2021-2022 | |
| Stryker Corporation | $156.11 | 2020 | |
| Abbvie INC. | $111.47 | 2025 | |
| Abbott Laboratories | $92.02 | 2019-2024 | Proclaim |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $71.63 | 2020 | |
| Medtronic, INC. | $58.40 | 2021-2024 | Intellis Adaptivestim |
| Baxter Healthcare | $55.52 | 2022 | |
| Painteq LLC | $49.97 | 2023 | Painteq |
| Depuy Synthes Sales INC. | $37.84 | 2019 | |
| Globus Medical, INC. | $29.12 | 2025 | Senza |
| Curonix LLC | $28.30 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Heron Therapeutics, INC. | $27.61 | 2023 | Zynrelef |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $25.89 | 2020 | |
| Spr Therapeutics, INC | $24.75 | 2023 | Sprint Pns System |
| Medline Industries Lp | $23.34 | 2025 | |
| Biotronik Nro, INC. | $20.34 | 2024 | Prospera |
| Lilly USA, LLC | $15.23 | 2019 | |
| Pfizer INC. | $13.98 | 2020 | |
| Mml US, INC. | $9.36 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.